Appeal No. 2001-0562 Page 5 Application No. 08/460,478 the claims are not enabled for any and all means of delivering the adenovirus to CNS cells in vivo. The standing rejection of [these] claims … could be overcome by limiting [these] claims … such that when the adenovirus is administered to central nervous system cells in vivo, it is done so by stereotactical injection (as in claims 83 and 84). To support this position, the examiner relies on Friedmann (Answer, page 13) arguing that Friedmann teach: the CNS is not freely accessible through the general bloodstream (see Friedmann, page 210, col. 1, para. 2), so it is unclear how one can infect CNS cells by a systemic route, such as intravenous, oral, anal, respiratory delivery, since one skilled in the art would not expect the adenovirus to reach cells of the CNS, at least not in any effective quantity. While we note that appellants argue (Reply Brief, page 2) that neither Friedman, nor the examiner define the phrase “freely accessible,” in our review of Friedmann, at page 210, column 1, paragraph 2, we are unable to find the phrase “freely accessible.” Instead, the first sentence of paragraph 2 on page 210, column 1, Friedman states “[i]t is now evident that assessments of the application of human gene therapy should be extended to neurological disorders.” In this same paragraph, Friedman states: Disorders of the CNS … were generally not prominent candidates for gene therapy in most early discussions … the perceived physical inaccessibility of the CNS, and physiological barriers to the introduction of gene transfer vectors through the blood-brain barrier combined to make gene therapy seem less feasible in the CNS than in other organs. In the third paragraph of page 210, column 1, Friedman states “[f]ortunately, these reservations regarding the feasibility of gene therapy for neurological disorders are now fading….” Therefore, we agree with appellants’ argument (Reply Brief, page 3) that “there is no basis in the record to support thePage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 NextLast modified: November 3, 2007